PMID: 8948496Nov 14, 1996Paper

Antioxidant properties of isotorachrysone isolated from Rhamnus nakaharai

Biochimica Et Biophysica Acta
G HsiaoC M Teng

Abstract

Isotorachrysone inhibited iron-induced lipid peroxidation with an IC50 value of 1.64 +/- 0.08 microM in rat brain homogenates, and was comparable in potency to butylated hydroxytoluene and was more potent than alpha-tocopherol or desferrioxamine. The mechanism of antioxidant properties were then examined. Isotorachrysone could scavenge the stable free radical diphenyl-p-picrylhydrazyl. And it was an efficient direct scavenger of water-soluble peroxyl radicals with stoichiometry factor of 0.53 +/- 0.05 in the aqueous phase and also toward lipid-soluble peroxyl radicals in tissue homogenates. The oxygen consumption during peroxidation induced by radicals on human erythrocyte ghosts was suppressed by isotorachrysone. Furthermore, it was reactive towards superoxide anion with a second-order rate constant of 5.06 +/- 0.65 x 10(5) M-1 S-1. But it did not react with hydrogen peroxide detected within the sensitivity limit of our assay. Using ascorbate/iron ion/H2O2 as a hydroxyl radical generating system and deoxyribose as a probe, isotorachrysone was effective with hydroxyl radicals with a second-order rate constant of 3.88 +/- 0.54 x 10(11) M-1 S-1 under stimulation by iron-EDTA. On the other hand, isotorachrysone retarded the peroxi...Continue Reading

References

Sep 8, 1978·Science·I Fridovich
Oct 1, 1992·Free Radical Biology & Medicine·H EsterbauerG Jürgens
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·S PicardJ L Witztum
Dec 1, 1991·The Journal of Clinical Investigation·J L Witztum, D Steinberg
Jan 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·I BjörkhemP Henriksson
Jan 1, 1990·Free Radical Research Communications·B Halliwell
Jan 1, 1990·Methods in Enzymology·B Halliwell, J M Gutteridge
Nov 1, 1990·Carcinogenesis·A RahmanJ H Parish
Oct 25, 1990·Nucleic Acids Research·R D AndersenH R Herschman
Jan 15, 1990·The Biochemical Journal·W JessupD S Leake
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Apr 1, 1989·Atherosclerosis·N G ArdlieL A Simons
May 1, 1986·Archives of Biochemistry and Biophysics·B Halliwell, J M Gutteridge
Mar 12, 1987·Journal of Immunological Methods·H Gyllenhammar
Oct 15, 1988·Biochemical Pharmacology·J M BraughlerG L Bundy
Jan 1, 1984·Methods in Enzymology·N A Porter
May 17, 1995·Biochemical Pharmacology·B Halliwell
Jun 1, 1995·The Journal of Clinical Investigation·P HolvoetD Collen
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·B N AmesT M Hagen
Apr 1, 1993·Free Radical Biology & Medicine·T SugiharaR P Hebbel
May 1, 1993·Stroke; a Journal of Cerebral Circulation·J A ClemensJ A Panetta
Dec 1, 1995·Journal of Natural Products·C N LinC M Teng
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON
Jan 1, 1963·Archives of Biochemistry and Biophysics·J T DODGED J HANAHAN
Feb 25, 2005·Neurology·H T F M VerzijlG W Padberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.